Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines / U.S. Department of Health and Human Services ; Prepared by the Office of the Assistant Secretary for Planning and Evaluation

United States Government Publishing Office publisher pbl distributor dst United States Health and Human Services Department author aut Government Organization text government publication eng GOVPUB Executive Agency Publications executive 2024-07-02 Health and Human Services Department 2022-01-01 monographic harvested born digital 22 digital object pages HE 1.2:OP 3/3 https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo213242 P0b002ee1c871c3b7 001217407 https://purl.fdlp.gov/GPO/gpo213242 (OCoLC)1380764348 DGPO 2024-07-02 2026-06-26 GOVPUB-HE-PURL-gpo213242 machine generated eng fdlp HE GOVPUB-HE-PURL-gpo213242 PURL-gpo213242 GOVPUB This content was harvested from online sources of the original hosting or authoring agency and may not reflect current policy. As Federal agencies add publications to their websites, or report new publications to GPO per statutory mandate (44 U.S.C. §§ 1710, 1902-1903), GPO ensures long-term preservation of and access to the content. 2022 BIBCONEW 20230531 UNREPORTEDPUBSSTAFF PERM_INGEST_12292023 gpo213242 https://www.govinfo.gov/app/details/GOVPUB-HE-PURL-gpo213242 https://www.govinfo.gov/content/pkg/GOVPUB-HE-PURL-gpo213242/pdf/GOVPUB-HE-PURL-gpo213242.pdf Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines / U.S. Department of Health and Human Services ; Prepared by the Office of the Assistant Secretary for Planning and Evaluation Buprenorphine Drug abuse Drugs Opioid abuse Overdose Prevention Time-series analysis 0445 (online) United States Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation, creator author. dcu U.S. Department of Health and Human Services 2022. monographic 1 online resource (21 pages) : illustration (chiefly color) HE 1.2:OP 3/3 0445 (online) text bibliography eng "December 2, 2022." In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP). Includes bibliographical references (pages 19-21). n-us--- Drug abuse Prevention Drugs Overdose Opioid abuse Buprenorphine Time-series analysis https://purl.fdlp.gov/GPO/gpo213242 https://aspe.hhs.gov/sites/default/files/documents/facbce1704035fded1034192d148304d/buprenorphine-practice-guideline-early-impacts.pdf Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines / U.S. Department of Health and Human Services ; prepared by the Office of the Assistant Secretary for Planning and Evaluation Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS buprenorphine practice guidelines / U.S. Department of Health and Human Services ; prepared by the Office of the Assistant Secretary for Planning and Evaluation